Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B9 pseudogene 2 (NDUFB9P2)

Target
NDUFB9P2
Molecular classification
Other (Pseudogene)
01

Overview

NADH:ubiquinone oxidoreductase subunit B9 pseudogene 2 (NDUFB9P2) is a processed pseudogene related to the protein-coding gene NDUFB9, which encodes a subunit of mitochondrial complex I (NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9)[1][4]. Pseudogenes like NDUFB9P2 generally arise from duplication or retrotransposition events and do not encode a functional protein[4]. While some pseudogenes regulate gene expression via noncoding RNA or by acting as microRNA decoys, there is no current evidence that NDUFB9P2 has any established biological function, disease association, or value as a drug target[1][2][4]. Pseudogenes can complicate genetic studies and annotations but do not typically serve as receptors, enzymes, or other canonical therapeutic targets[4]. NDUFB9P2 is a pseudogene with no established function, clinical relevance, or drug target potential, in contrast to its parent gene NDUFB9 which encodes a functional mitochondrial complex I subunit. NDUFB9P2 should not be used as a synonym for NDUFB9.

Other names
NDUFB9P2
02

Mechanism of action

Not applicable (no known drugs or therapeutic modulation)

03

Biological functions

May participate in regulatory noncoding RNA functions typical of some pseudogenes, but not established for NDUFB9P2 specifically
04

Disease associations

None established for NDUFB9P2; general pseudogene roles sometimes relate to cancer or gene regulation, but not for this specific entry

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B9 pseudogene 2 (NDUFB9P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B9 pseudogene 2 (NDUFB9P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call